OneMedNet director Kosasa buys $750K in shares

The subscription agreement covered a $750,000 investment, with shares valued at the issuer's VWAP for the preceding 10 trading days.

Rhea-AI Filing Summary

OneMedNet Corp (ONMD) director and 10% owner Thomas Kosasa purchased 129,758 common shares directly on October 7, 2026, at $5.78 per share. OneMedNet entered into a subscription agreement with Kosasa for a $750,000 investment. His reported direct holdings after the purchase were 1,983,573 shares; no Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Buyer: 129,758 shares

Net Buy 1 txn

Insider Kosasa Thomas

Role Director, 10% Owner

Bought 129,758 shs ($750K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F2	129,758	$5.78	$750K

Holdings After Transaction: Common Stock — 1,983,573 shares (Direct)

Footnotes (2)

1. F1. On October 7, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer.
2. F2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

Key Figures

Shares purchased: 129,758 shares Price per share: $5.78 per share Investment: $750,000 +2 more

5 metrics

Shares purchased 129,758 shares Thomas Kosasa's direct purchase on October 7, 2026

Price per share $5.78 per share Thomas Kosasa's purchase on October 7, 2026

Investment $750,000 Subscription agreement with Thomas Kosasa

Direct shares following purchase 1,983,573 shares Thomas Kosasa's reported position after the transaction

VWAP reference period 10 trading days Immediately before the purchase date

Key Terms

volume-weighted average price (VWAP), subscription agreement, Rule 10b5-1 plan

3 terms

volume-weighted average price (VWAP) financial

"volume-weighted average price (VWAP) of the issuer"

Volume-weighted average price (VWAP) is the average price of a security over a trading period where each trade’s price is weighted by how many shares were traded, so larger trades pull the average more than tiny ones. Investors and traders use VWAP as a benchmark to judge whether a trade was executed at a favorable price—similar to checking whether you paid more or less than the typical price when most people were buying or selling.

subscription agreement financial

"subscription agreement with the reporting person"

A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

Rule 10b5-1 plan regulatory

"no Rule 10b5-1 plan is reported"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ONMD shares did Thomas Kosasa buy and at what price?

Thomas Kosasa purchased 129,758 ONMD common shares directly on October 7, 2026, at $5.78 per share.

How much did Thomas Kosasa agree to invest in OneMedNet?

OneMedNet entered into a subscription agreement with Thomas Kosasa for a $750,000 investment in the issuer.

How was the ONMD purchase price determined?

The shares were valued at the issuer's volume-weighted average price (VWAP) for the 10 trading days immediately before the purchase date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 08:35 PM EDT Accepted by SEC EDGAR 10/13/2026 - 08:32 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kosasa Thomas

(Last) (First) (Middle)

6385 OLD SHADY OAK ROAD, SUITE 250

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OneMedNet Corp [ ONMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/07/2026		P(1)		129,758	A	$5.78(2)	1,983,573	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 7, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer.

2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

	/s/ Robert Golden, Attorney-in-Fact	10/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)